SIRIO Europe launches LifeChews plant-based jelly tablets in Europe

Published: 13-Mar-2026

The contract manufacturer has introduced a patented chewable jelly tablet format clinically shown to achieve a 198% improvement in bioavailability for lipid-soluble nutrients, including omega-3s, fat-soluble vitamins and CoQ10

SIRIO Europe has announced the European launch of its patented, plant-based, chewable jelly tablet format LifeChews.

The launch is part of the company's global rollout of LifeChews.

According to the company, the format is clinically proven to significantly improve bioavailability, delivering "excellent dispersibility" across a wide range of oil-soluble actives while enabling high nutrient payloads.

As part of the launch, SIRIO will introduce a variety of turnkey concepts that utilise this unique format, allowing brands to provide supplements that are both effective and enjoyable—helping consumers establish lasting health habits.


Consumer decisions about supplements are increasingly influenced by sensory appeal and performance, with 43% seeking greater efficacy and 45% prioritising pleasant taste

Traditional challenges, such as poor dispersibility, oxidation and unpleasant aftertastes, have limited the development of lipid-based nutrient supplements in chewable formats. 


LifeChews address these issues by offering a delicious, plant-based chewable that delivers high-strength lipid-soluble nutrients, including omega-3 oils, fat-soluble vitamins, CoQ10 and carotenoids such as lutein and astaxanthin.

SIRIO says that it has developed four market-ready concepts using this innovative jelly tablet format, catering to the rising demand for tasty, effective supplements focused on brain, heart, immunity and longevity.

The patented LifeChews technology ensures the even dispersion of 5 μm oil droplets, similar in size to lipid particles in human milk, optimising absorption.

According to the company's release, studies showed that LifeChews led to a 161% increase in blood plasma DHA concentration compared to a control group, translating to a 198% improvement in bioavailability.

Additionally, digestion studies confirmed DHA distribution during simulated gastric and intestinal conditions, demonstrating the format's stability and efficiency.

For nutraceutical brands, this combination of scientific validation and a consumer-friendly, plant-based format offers a distinct advantage in the competitive omega-3 and lipid-based supplement markets.

"LifeChews are a game-changer in how consumers experience supplements," said Sara Lesina, General Manager, SIRIO Europe.

"They combine convenience, great taste and a really meaningful nutrient boost in a plant-based chewable jelly format people actually enjoy."

By bringing together clinical validation and a high payload capacity, LifeChews give our partner brands a powerful new way to stand out in key trending categories and deliver real added value to consumers.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like